Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An announcement from Cannabotech ( (IL:CNTC) ) is now available.
Cannabotech has appointed Nikita Lelyukh as a regular director, effective February 10, 2025. Lelyukh, who has experience as a marketing company owner and founding partner in a startup investment company, does not hold any securities in the company nor serves on its board committees. The appointment reflects Cannabotech’s strategic move to integrate skilled individuals with diverse backgrounds into its leadership team, potentially enhancing its market positioning and operational effectiveness.
More about Cannabotech
Cannabotech operates in the biotechnology industry, focusing on developing and commercializing botanical-based healthcare products. The company is listed on the Tel Aviv Stock Exchange, emphasizing its role in innovative health solutions.
YTD Price Performance: -26.42%
Average Trading Volume: 11,328
See more insights into CNTC stock on TipRanks’ Stock Analysis page.
